Clinical Trial Update: Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the concentration of the anti‑MS antibody ofatumumab in the breast milk of lactating women with relapsing forms of multip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Kesimpta (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING